Engineers Gate Manager’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-11,569
| Closed | -$440K | – | 2113 |
|
2022
Q4 | $440K | Buy |
+11,569
| New | +$440K | 0.03% | 978 |
|
2022
Q3 | – | Sell |
-22,877
| Closed | -$695K | – | 2195 |
|
2022
Q2 | $695K | Sell |
22,877
-3,847
| -14% | -$117K | 0.03% | 918 |
|
2022
Q1 | $875K | Buy |
26,724
+1,596
| +6% | +$52.3K | 0.03% | 748 |
|
2021
Q4 | $663K | Buy |
+25,128
| New | +$663K | 0.03% | 863 |
|
2020
Q2 | – | Sell |
-8,647
| Closed | -$1.25M | – | 2048 |
|
2020
Q1 | $1.25M | Buy |
+8,647
| New | +$1.25M | 0.09% | 337 |
|
2019
Q1 | – | Sell |
-23,727
| Closed | -$1.33M | – | 1210 |
|
2018
Q4 | $1.33M | Sell |
23,727
-16,387
| -41% | -$919K | 0.11% | 290 |
|
2018
Q3 | $3.28M | Buy |
40,114
+16,071
| +67% | +$1.31M | 0.25% | 115 |
|
2018
Q2 | $841K | Buy |
+24,043
| New | +$841K | 0.07% | 410 |
|